Responses
Poster Presentations
Psoriatic arthritis
THU0411 Secukinumab Efficacy in Anti-TNF-Naive and Anti-TNF-IR Patients with Psoriatic Arthritis: Results of a Phase 3 Multicenter, Double-Blind, Placebo-Controlled Study (Future 2)
Compose a Response to This Article
Other responses
No responses have been published for this article.